Search

#Pharmaceuticals
R
Reuters @reuters.com Β· London πŸ‡¬πŸ‡§ Β· 2d

The California Supreme Court will review a case involving Gilead Sciences, which is appealing lower court decisions allowing HIV patients to pursue negligence claims over the company's halt in developing a potentially safer alternative drug, a ruling that could reshape product liability law and impose a "duty to innovate" on drug manufacturers. #Pharmaceuticals #Innovation #ProductLiability #US

www.reuters.com
California's highest court to consider whether drugmakers have 'duty to innovate'
May 6 (Reuters) - The California Supreme Court will on Wednesday consider whether manufacturers of drugs that are considered safe are legally obligated to continue developing drugs that are allegedly safer.
R
Reuters @reuters.com Β· London πŸ‡¬πŸ‡§ Β· 2d

The California Supreme Court is set to review whether drug manufacturers, such as Gilead Sciences, are legally required to continue developing allegedly safer alternatives to their existing drugs, following a negligence claim from approximately 24,000 HIV patients regarding Gilead's decision to cease development of a new drug with fewer side effects. #Pharmaceuticals #ProductLiability #Innovation #US

www.reuters.com
California's highest court to consider whether drugmakers have 'duty to innovate'
May 6 (Reuters) - The California Supreme Court will on Wednesday consider whether manufacturers of drugs that are considered safe are legally obligated to continue developing drugs that are allegedly safer.
Jean Marc Morandini @morandiniblog Β· 4d

Anti-obesity ads: Pharmaceutical companies Novo Nordisk and Eli Lilly fined 2 million euros by the drug agency. (Original: PublicitΓ©s anti-obΓ©sitΓ©: Les laboratoires pharmaceutiques Novo Nordisk et Eli Lilly sanctionnΓ©s de 2 millions d'euros par l'agence du mΓ©dicament https://t.co/6qi067hLi8) #AntiObesity #Pharmaceuticals #HealthRegulation #DN #FI #NL